|
|||||
|
|
AURIEL-PsO: a randomized,double-blind phase III equivalence trial to demonstrate the clinical similarity of the proposed biosimilar MSB11022 to reference adalimumab in patients with moderate-to-severe chronic plaque-type psoriasis |
|
| Authors: | J. Hercogová K.A. Papp V. Chyrok M. Ullmann P. Vlachos C.J. Edwards |
| Affiliation: | 1. Dermatology Department, 2nd Medical Faculty, Charles University and Na Bulovce Hospital, Prague, Czech Republic;2. K Papp Clinical Research and Probity Medical Research Inc., Waterloo, ON, Canada;3. Fresenius Kabi, Eysin, Switzerland;4. Cytel, Geneva, Switzerland;5. NIHR Clinical Research Facility, University of Southampton, Southampton, U.K. |
| Abstract: | |
| Keywords: | |